Eden Research plc

Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.

For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.

Quality Assistance S.A. is an expert for the development of:
- Biologics (monoclonal antibodies, ADCs, proteins)
- New Chemical Entities, oligonucleotides, peptides
- Nanomedicine products
- Vaccines
- Cell-Based and Gene Therapy Medicinal Products

The company holds a unique position on the market with:
All its laboratories on one site (Donstiennes, Belgium)
- Bioanalysis (PK/TK/Immuno)
- Bioassays
- Biochemistry
- Chromatography
- Elemental Impurities
- Mass Spectrometry
- Microbiology
- Molecular Biology
- Protein Characterisation
200 highly qualified professionals
more than 35 years’ expertise at the forefront of analytical sciences.

Our core competencies are:
QUALITY (CMC)
- Development and validation of analytical methods
- Characterisation
- Stability studies
- Batch (release) testing
SAFETY/EFFICACY (Bioanalysis)
- Development and validation of bioanalytical methods
- PK/TK studies
- Immunogenicity studies
- Biomarker studies

The Quality Assistance environment is GMP, GLP and GCLP/GCP compliant.

Visit www.quality-assistance.com for more information

APR is a Swiss independent pharma company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases.

APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management.

A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases.

Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.

Contact Us: aurenalabs.com | contact@aurenalabs.se

AURENA Laboratories AB is a pioneer in the field of clean room produced Bag-on-Valve aerosols. We have specialized in the development and filling of a new generation of spray products based on Bag-on-Valve aerosols packaging.

Our unique Bag-on-Valve aerosols system is developed to not only produce a superior spray dispensing system, but to reduce our ecological footprint through a sustainable packaging process.

Our customers and partners are often international companies in the pharmaceutical, healthcare, medical device and safety industries. Examples of some of our pharma and medical device products are:

• Saline solution sprays/seawater nasal sprays
• Wound treatment sprays
• Eye wash sprays
• Medical adhesive remover sprays
• Throat sprays
• Emollient sprays
• Ear sprays

The Bag-on-Valve system offers major advantages for a range of aerosol products where a safe and contact- free dispensing is required for products with different consistencies, liquids as well as viscous products. Bag-on-Valve gives new marketing opportunities through improved consumer conveniences, product protection and controlled discharge of the product.

For our customers we offer a range of registered products in customer brands that are regulated and approved as sterile medical devices and comply with the European Medical device Directive. We also offer contract manufacturing of Bag-on-Valve products and aerosols.

www.bagonvalve.com www.aurena.se

Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Our proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.

Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest and largest growing segments of the US$6.5 billion molecular diagnostics market. Biocartis employs over 500 people and is headquartered in Mechelen, Belgium. Further information? Visit www.biocartis.com

Software driven by machine learning that allows the chemical industry to model chemistry, improve yield and generate new chemical leads.

The ChemAlive platform is designed for cheaper and faster access to computed chemical data with no expertise, hardware or software barrier through a SaaS model executable by any chemist on-line. Our system brings machine learning and big data to the chemical and Pharma industry who have a need for accurate reaction metrics to design, predict and understand chemical processes. The efficiency and reliability of our approach opens up new markets where interactive accurate data can be used as a sales, marketing and R&D tool.

We target industrial chemistry companies and Pharma who have a need for accurate reaction metrics to design, predict and understand chemical processes. We already work with multi-national petro-chemicals and two CROs in Pharma for development of production scale reactions. Over 20 companies are testing our software.